Related references
Note: Only part of the references are listed.Genetic characterization of human coxsackievirus A6 variants associated with atypical hand, foot and mouth disease: a potential role of recombination in emergence and pathogenicity
Eleanor Gaunt et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014
She-Lan Liu et al.
REVIEWS IN MEDICAL VIROLOGY (2015)
Construction and characterization of an infectious clone of coxsackievirus A6 that showed high virulence in neonatal mice
Lisheng Yang et al.
VIRUS RESEARCH (2015)
A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71
Longfa Xu et al.
SCIENTIFIC REPORTS (2015)
Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice
Hui Zhao et al.
SCIENTIFIC REPORTS (2015)
Review of Enterovirus 71 Vaccines
Pele Chong et al.
CLINICAL INFECTIOUS DISEASES (2015)
Coxsackievirus A6 and enterovirus 71 causing hand, foot and mouth disease in Cuba, 2011-2013
Magile C. Fonseca et al.
ARCHIVES OF VIROLOGY (2014)
Epidemiological and clinical characteristics of children who died from hand, foot and mouth disease in Vietnam, 2011
Ngoc T. B. Nguyen et al.
BMC INFECTIOUS DISEASES (2014)
Molecular epidemiology of enterovirus 71, coxsackievirus AI6 and A6 associated with hand, foot and mouth disease in Spain
M. Cabrerizo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates
Jingliang Li et al.
JOURNAL OF GENERAL VIROLOGY (2014)
Cryo-Electron Microscopy Study of Insect Cell-Expressed Enterovirus 71 and Coxsackievirus A16 Virus-Like Particles Provides a Structural Basis for Vaccine Development
Minqing Gong et al.
JOURNAL OF VIROLOGY (2014)
Atypical hand, foot, and mouth disease: a vesiculobullous eruption caused by Coxsackie virus A6
Henry M. Feder et al.
LANCET INFECTIOUS DISEASES (2014)
An Inactivated Enterovirus 71 Vaccine in Healthy Children
Rongcheng Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses
Yicun Cai et al.
VACCINE (2014)
Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases
Chia-Chyi Liu et al.
VACCINE (2014)
A Novel Universal Neutralizing Monoclonal Antibody against Enterovirus 71 That Targets the Highly Conserved Knob Region of VP3 Protein
Tanja K. Kiener et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Immunogenicity Studies of Bivalent Inactivated Virions of EV71/CVA16 Formulated with Submicron Emulsion Systems
Chih-Wei Lin et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Risk Factors for Neurologic Complications of Hand, Foot and Mouth Disease in the Republic of Korea, 2009
Seong Joon Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2013)
Atypical hand-foot-and-mouth disease associated with coxsackievirus A6 infection
Jason P. Lott et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Feng-Cai Zhu et al.
LANCET (2013)
Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial
Feng-Cai Zhu et al.
LANCET (2013)
Adaptation of Enterovirus 71 to Adult Interferon Deficient Mice
Elizabeth A. Caine et al.
PLOS ONE (2013)
The Cross-Neutralizing Activity of Enterovirus 71 Subgenotype C4 Vaccines in Healthy Chinese Infants and Children
Qunying Mao et al.
PLOS ONE (2013)
Transgenic mouse model for the study of enterovirus 71 neuropathogenesis
Ken Fujii et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16
Jinping Shi et al.
VACCINE (2013)
Picornavirus uncoating intermediate captured in atomic detail
Jingshan Ren et al.
NATURE COMMUNICATIONS (2013)
Preclinical Evaluation of the Immunogenicity and Safety of an Inactivated Enterovirus 71 Candidate Vaccine
Shi-Hsia Hwa et al.
PLOS NEGLECTED TROPICAL DISEASES (2013)
Enteroviruses in Patients Experiencing Multiple Episodes of Hand, Foot, and Mouth Disease in the Same Season in Kobe, Japan, 2011
Kyoko Akiyoshi et al.
JAPANESE JOURNAL OF INFECTIOUS DISEASES (2012)
Seroepidemiology of Enterovirus 71 infection prior to the 2011 season in children in Shanghai
Mei Zeng et al.
JOURNAL OF CLINICAL VIROLOGY (2012)
Protection from Secondary Dengue Virus Infection in a Mouse Model Reveals the Role of Serotype Cross-Reactive B and T Cells
Simona Zompi et al.
JOURNAL OF IMMUNOLOGY (2012)
Seroprevalence of enterovirus 71 and no evidence of crossprotection of enterovirus 71 antibody against the other enteroviruses in kindergarten children in Taipei city
Wen-Chan Huang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2012)
A Non-Mouse-Adapted Enterovirus 71 (EV71) Strain Exhibits Neurotropism, Causing Neurological Manifestations in a Novel Mouse Model of EV71 Infection
Wei Xin Khong et al.
JOURNAL OF VIROLOGY (2012)
A Neonatal Mouse Model of Coxsackievirus A16 for Vaccine Evaluation
Qunying Mao et al.
JOURNAL OF VIROLOGY (2012)
Characterization of an Isotype-Dependent Monoclonal Antibody against Linear Neutralizing Epitope Effective for Prophylaxis of Enterovirus 71 Infection
Xiao Fang Lim et al.
PLOS ONE (2012)
Enterovirus 71-Induced Neurological Disorders in Young Gerbils, Meriones unguiculatus: Development and Application of a Neurological Disease Model
Ping-Ping Yao et al.
PLOS ONE (2012)
Crystal Structure of Human Enterovirus 71
Pavel Plevka et al.
SCIENCE (2012)
Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice
Joseph N. Brewoo et al.
VACCINE (2012)
Cellular receptors for human enterovirus species A
Yorihiro Nishimura et al.
FRONTIERS IN MICROBIOLOGY (2012)
A mouse muscle-adapted enterovirus 71 strain with increased virulence in mice
Wei Wang et al.
MICROBES AND INFECTION (2011)
The largest outbreak of hand; foot and mouth disease in Singapore in 2008: The role of enterovirus 71 and coxsackievirus A strains
Yan Wu et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2010)
CD4+ T Cells Are Not Required for the Induction of Dengue Virus-Specific CD8+ T Cell or Antibody Responses but Contribute to Protection after Vaccination
Lauren E. Yauch et al.
JOURNAL OF IMMUNOLOGY (2010)
Virology, epidemiology, pathogenesis, and control of enterovirus 71
Tom Solomon et al.
LANCET INFECTIOUS DISEASES (2010)
Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types
Ting Zhang et al.
VACCINE (2010)
A Protective Role for Dengue Virus-Specific CD8+ T Cells
Lauren E. Yauch et al.
JOURNAL OF IMMUNOLOGY (2009)
Coxsackievirus A6 and Hand, Foot, and Mouth Disease, Finland
Riikka Osterback et al.
EMERGING INFECTIOUS DISEASES (2009)
Identification of immunodominant VP1 linear epitope of enterovirus 71 (EV71) using synthetic peptides for detecting human anti-EV71 IgG antibodies in western blots
D. G. W. Foo et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection
YF Wang et al.
JOURNAL OF VIROLOGY (2004)
A murine oral enterovirus 71 infection model with central nervous system involvement
YC Chen et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Complete genome sequences of all members of the species Human enterovirus A
MS Oberste et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Share Paper
